0.5351
-0.0031
(-0.58%)
As of 3:14:23 PM EDT. Market Open.
Research Analysis
Earnings Estimate
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | 1 | 1 | 1 | -- |
| Avg. Estimate | -0.17 | -0.19 | -0.99 | 0 |
| Low Estimate | -0.17 | -0.19 | -0.99 | 0 |
| High Estimate | -0.17 | -0.19 | -0.99 | 0 |
| Year Ago EPS | -0.53 | -0.49 | -2.02 | -0.99 |
Revenue Estimate
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | 1 | 1 | 1 | -- |
| Avg. Estimate | -- | -- | -- | -- |
| Low Estimate | -- | -- | -- | -- |
| High Estimate | -- | -- | -- | -- |
| Year Ago Sales | -- | 350k | 4.49M | -- |
| Sales Growth (year/est) | 0.00% | -100.00% | -100.00% | -- |
Earnings History
| Currency in USD | 3/31/2024 | 6/30/2024 | 9/30/2024 | 12/31/2024 |
|---|---|---|---|---|
| EPS Est. | -0.5 | -0.56 | -0.51 | -0.42 |
| EPS Actual | -0.53 | -0.49 | -0.39 | -0.12 |
| Difference | -0.03 | 0.07 | 0.12 | 0.3 |
| Surprise % | -6.71% | 11.71% | 23.53% | 71.43% |
EPS Trend
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Current Estimate | -0.17 | -0.19 | -0.99 | 0 |
| 7 Days Ago | -0.46 | -0.43 | -1.66 | 0 |
| 30 Days Ago | -0.46 | -0.43 | -1.66 | 0 |
| 60 Days Ago | -0.46 | -0.43 | -1.66 | 0 |
| 90 Days Ago | -0.46 | -0.43 | -1.66 | 0 |
EPS Revisions
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Up Last 7 Days | 1 | 1 | 1 | -- |
| Up Last 30 Days | 1 | 1 | 1 | -- |
| Down Last 7 Days | -- | -- | -- | -- |
| Down Last 30 Days | -- | -- | -- | -- |
Growth Estimates
| Current Qtr. | Next Qtr. | Current Year | Next Year | |
|---|---|---|---|---|
| PTN | 67.92% | 61.22% | 50.99% | -- |
| S&P 500 | 6.69% | 6.80% | 9.98% | 14.34% |
Upgrades & Downgrades
| Maintains | HC Wainwright & Co.: Buy to Buy | 2/13/2025 |
| Reiterates | HC Wainwright & Co.: Buy to Buy | 2/7/2025 |
| Reiterates | HC Wainwright & Co.: Buy to Buy | 12/19/2024 |
| Reiterates | HC Wainwright & Co.: Buy to Buy | 11/25/2024 |
| Reiterates | HC Wainwright & Co.: Buy to Buy | 11/4/2024 |
| Reiterates | HC Wainwright & Co.: Buy to Buy | 10/31/2024 |
Related Tickers
THAR Tharimmune, Inc.
1.2500
-3.10%
SNSE Sensei Biotherapeutics, Inc.
0.3302
-9.78%
RNAZ TransCode Therapeutics, Inc.
0.4719
-10.61%
CMPX Compass Therapeutics, Inc.
1.6400
-2.96%
PHGE BiomX Inc.
0.5801
-7.77%
RGLS Regulus Therapeutics Inc.
1.8050
-7.91%
CERO CERo Therapeutics Holdings, Inc.
0.6900
-5.30%
IBO Impact BioMedical Inc.
0.4630
-18.84%
PSTV Plus Therapeutics, Inc.
0.7777
-12.64%
DRMA Dermata Therapeutics, Inc.
0.9231
-6.78%